Literature DB >> 24633618

B cell biology: an overview.

Hermann Eibel1, Helene Kraus, Heiko Sic, Anne-Kathrin Kienzler, Marta Rizzi.   

Abstract

In this review we summarize recent insights into the development of human B cells primarily by studying immunodeficiencies. Development and differentiation of B cells can be considered as a paradigm for many other developmental processes in cell biology. However, it differs from the development of many other cell types by phases of extremely rapid cell division and by defined series of somatic recombination and mutation events required to assemble and refine the B cell antigen receptors. Both somatic DNA alteration and proliferation phases take place in defined sites but in different organs. Thus, cell migration and timely arrival at defined sites are additional features of B cell development. By comparing experimental mouse models with insights gained from studying defined genetic defects leading to primary immunodeficiencies and hypogammaglobulinemia, we address important features that are characteristic for human B cells. We also summarize recent advances made by developing improved in vitro and in vivo systems allowing the development of human B cells from hematopoietic stem cells. Combined with genetic and functional studies of immunodeficiencies, these models will contribute not only to a better understanding of disease affecting the B lymphocyte compartment, but also to designing better and safer novel B cell-targeted therapies in autoimmunity and allergy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24633618     DOI: 10.1007/s11882-014-0434-8

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  177 in total

1.  Development of a human adaptive immune system in cord blood cell-transplanted mice.

Authors:  Elisabetta Traggiai; Laurie Chicha; Luca Mazzucchelli; Lucio Bronz; Jean-Claude Piffaretti; Antonio Lanzavecchia; Markus G Manz
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

Review 2.  Germinal centers.

Authors:  I C MacLennan
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

3.  CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.

Authors:  Menno C van Zelm; Julie Smet; Brigitte Adams; Françoise Mascart; Liliane Schandené; Françoise Janssen; Alina Ferster; Chiung-Chi Kuo; Shoshana Levy; Jacques J M van Dongen; Mirjam van der Burg
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

4.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.

Authors:  Ryan T Phan; Riccardo Dalla-Favera
Journal:  Nature       Date:  2004-12-02       Impact factor: 49.962

5.  Failure of B-cell differentiation in mice lacking the transcription factor EBF.

Authors:  H Lin; R Grosschedl
Journal:  Nature       Date:  1995-07-20       Impact factor: 49.962

6.  Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation.

Authors:  Chainarong Tunyaplin; A L Shaffer; Cristina D Angelin-Duclos; Xin Yu; Louis M Staudt; Kathryn L Calame
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

7.  Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells.

Authors:  Jérôme Pène; Jean-François Gauchat; Sandrine Lécart; Elodie Drouet; Paul Guglielmi; Vera Boulay; Adriana Delwail; Don Foster; Jean-Claude Lecron; Hans Yssel
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

8.  Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells.

Authors:  Kuo-I Lin; Cristina Angelin-Duclos; Tracy C Kuo; Kathryn Calame
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

9.  Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow.

Authors:  Miriam Shapiro-Shelef; Kuo-I Lin; David Savitsky; Jerry Liao; Kathryn Calame
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

Review 10.  Pax5: the guardian of B cell identity and function.

Authors:  César Cobaleda; Alexandra Schebesta; Alessio Delogu; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2007-05       Impact factor: 25.606

View more
  23 in total

1.  Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion.

Authors:  Yan Xiu; Qianze Dong; Lin Fu; Aaron Bossler; Xiaobing Tang; Brendan Boyce; Nicholas Borcherding; Mariah Leidinger; José Luis Sardina; Hai-Hui Xue; Qingchang Li; Andrew Feldman; Iannis Aifantis; Francesco Boccalatte; Lili Wang; Meiling Jin; Joseph Khoury; Wei Wang; Shimin Hu; Youzhong Yuan; Endi Wang; Ji Yuan; Siegfried Janz; John Colgan; Hasem Habelhah; Thomas Waldschmidt; Markus Müschen; Adam Bagg; Benjamin Darbro; Chen Zhao
Journal:  Blood       Date:  2020-01-09       Impact factor: 22.113

2.  IL4 (interleukin 4) induces autophagy in B cells leading to exacerbated asthma.

Authors:  Fucan Xia; Changwen Deng; Yanyan Jiang; Yulan Qu; Jiewen Deng; Zhijian Cai; Yuanyuan Ding; Zhenhong Guo; Jianli Wang
Journal:  Autophagy       Date:  2018-02-01       Impact factor: 16.016

Review 3.  B cells in systemic sclerosis: from pathophysiology to treatment.

Authors:  Konstantinos Melissaropoulos; Dimitrios Daoussis
Journal:  Clin Rheumatol       Date:  2021-03-21       Impact factor: 2.980

4.  Principles in Immunology for the Design and Development of Vaccines.

Authors:  Claudius U Meyer; Fred Zepp
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis.

Authors:  Malik R Seals; Monica M Moran; Jonathan D Leavenworth; Jianmei W Leavenworth
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 6.  Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials.

Authors:  Harry Alexopoulos; Angie Biba; Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 7.  A Review of the Various Roles and Participation Levels of B-Cells in Non-Infectious Uveitis.

Authors:  Lei Zhu; Binyao Chen; Wenru Su
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

Review 8.  Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases.

Authors:  Panos Stathopoulos; Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2022-02-18       Impact factor: 6.088

Review 9.  Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change.

Authors:  Tamas Fulop; Anis Larbi; Graham Pawelec; Alan A Cohen; Guillaume Provost; Abedelouahed Khalil; Guy Lacombe; Serafim Rodrigues; Mathieu Desroches; Katsuiku Hirokawa; Claudio Franceschi; Jacek M Witkowski
Journal:  Vaccines (Basel)       Date:  2022-04-13

10.  Defective Bcl-2 expression in memory B cells from common variable immunodeficiency patients.

Authors:  L Del Pino Molina; J M Torres Canizales; O Pernía; R Rodríguez Pena; I Ibanez de Caceres; E López Granados
Journal:  Clin Exp Immunol       Date:  2020-10-08       Impact factor: 5.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.